Advisortrust Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Advisortrust Partners's LLY Position: Q3 2026 in Review
Advisortrust Partners increased its Eli Lilly (LLY) stake by 2% in Q3 2026, buying an estimated $34.2K and bringing the position to 1,502 shares worth $1.74M. The position accounts for 0.55% of the portfolio, ranked #41.
Advisortrust Partners first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.77M in Q2 2026. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Advisortrust Partners held 1,502 shares of Eli Lilly worth $1.74M as of Q3 2026.
- Advisortrust Partners bought 29 Eli Lilly shares in Q3 2026, an estimated $34.2K.
- Eli Lilly made up 0.55% of Advisortrust Partners's portfolio in Q3 2026, its #41 holding.
- Advisortrust Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- Advisortrust Partners's Eli Lilly position peaked at $1.77M in Q2 2026.
- 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Advisortrust Partners's 13F filing for Q3 2026, filed 2 Nov 2026.